|
|
| Type: |
Oral Abstract Sessions |
| Venue: |
Sao Paulo |
| Time: |
10:20 - 11:50 |
| Chairpersons: |
Charlie Gilks, WHO N. Kumarasamy, India |
|
Presentations in this session:
10:20
MoOa0201
Abstract
Powerpoint
|
The Chilean AIDS cohort (ChiAC): impact of an expanded access program to HAART in survival and risk factors for mortality in a treatment naïve population:
Beltrán C.1, Wolff M.1, Vásquez P.1, Berna L.1, Carreño J.1, Toro C.1, Chahín C.1
1Chilean AIDS Study Group, Santiago, Chile
|
|
10:35
MoOa0202
Abstract
|
Implementing an antiretroviral treatment program in a Nairobi slum, Kenya
Macharia D.1, Ngan'ga L.W.1, Wangai M.2, Isavwa A.1, Ilako F.3, Marston B.1, DeCock K.1, Weidle P.J.4
1Centers for Disease Control & Prevention/Kenya, Nairobi, Kenya, 2Kenya Ministry of Health, Nairobi, Kenya, 3African Medical Research Foundation, Nairobi, Kenya, 4Centers for Disease Control & Prevention, Atlanta, United States of America
|
|
10:50
MoOa0203
Abstract
Powerpoint
|
6-month immunological response with HAART containing Nevirapine in HIV infected women post exposure to single dose of Nevirapine for PMTCT. The MTCT-Plus Initiave in Abidjan, Côte d’Ivoire (2003-2005).
Bedikou G.1, Viho I.1, Tonwe-Gold B.1, Coffie J.P.2, Amani-Bosse C.1, Allou G.1, Sakarovitch C.2, Toure S.1, Ekouevi D.K.1, Leroy V.2, Abrams E.J.3, Dabis F.2
1Programme MTCT-Plus, Aconda, Abidjan, Côte D'Ivoire, 2Unité INSERM 593, Institut De Santé Publique, Epidémiologie Et Développement (ISPED), Bordeaux, France, 3The MTCT-Plus Initiative, Mailman School Of Public Healths, Columbia University, New-York, United States of America
|
|
11:05
MoOa0204
Abstract
|
Generic drugs, health delivery mode and effectiveness of HAART in Brazil
May S.1, Barroso P.1, Santoro Lopes G.1, Nunes E.1, Barcaui H.2, Costa M.2, Almeida M.1, Faulhaber J.1, Schechter M.1
1Projeto Praça Onze, Univ. Federal do Rio de Janeiro, Rio de Janeiro, Brazil, 2Univ. Federal do Rio de Janeiro, Rio de Janeiro, Brazil
|
|
11:20
MoOa0205
Abstract
|
Peer counselors as a strategy to educate and maintain adherence levels in community antiretroviral clinics in South Africa
Bekker L.-G.1, Mtwisha L.1, Orrell C.1, Rivett U.2, Wood R.1
1Desmond Tutu HIV Centre, Cape Town, South Africa, 2Cell Life, University of Cape Town, South Africa
|
|
11:35
MoOa0206
Abstract
|
Expansion of HIV/AIDS care and treatment programs in 5 countries in Sub Saharan Africa
Nash D.1, Hoos D.1, Rosenthal M.1, Musick B.2, Fraser Chanpong G.3, Reed K.4, Casey S.5, Hawken M.3, Macharia D.4, Lima J.6, El Sadr W.1
1Columbia University, Mailman School of Public Health, New York, United States of America, 2Indiana University, Indianapolis, United States of America, 3Columbia University Tanzania, Dar Es Salaam, United Republic of Tanzania, 4Columbia University South Africa, East London, South Africa, 5Columbia University Rwanda, Kigali, Rwanda, 6Columbia University Mozambique, Maputo, Mozambique
|
|
|